Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development
Member News
The MoU was signed during the official, 40thanniversary celebration ceremony of the Shanghai-Rotterdam Sister City Relationship.
Related or similar articles
November 14, 2018
Science incubator Labshares Newton is Set to Expand
The next groundbreaking medical discovery could be made right here in the city, as companies conduct research and experiments at Labshares Newton, an “incubator lab” on Bridge Street that is in the process of expanding.
Labshares News
March 26, 2019
Abcuro announces pre-clinical data on new immuno-oncology target
First in vivo validation of KLRG1 as a new cancer immunotherapy target
Member News
April 28, 2020
Labshares Newton Awards Free Project-Based Lab Space to Three Innovative Diagnostics Companies Conducting COVID-19 Research
Labshares Newton, a shared office and laboratory incubator for emerging biotechnology and life science companies, today announced that it has selected three startup companies developing COVID-19 diagnostics to receive free lab space. The companies...
Labshares News